A5418 Study of Tecovirimat for Human Monkeypox Virus (STOMP)  

You must have a positive laboratory test for monkeypox virus within 14 days of enrolling in the study and at least one skin lesion. Participants with severe disease, significant skin conditions, participants with severe immune suppression will receive open-label tecovirimat.